Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Wednesday, April 1, 2015
NC Committee gives nod to biosimilar drugs
Committee gives nod to 'biosimilar' drugs
WRAL.com-3 hours ago
Raleigh, N.C. — North Carolina would join the growing list of states to prescribe howpharmacists may substitute ...
Diplomat Pharmacy raises some $200 million in follow-on stock ...
Diplomat Pharmacy raises some $200 million in follow-on stock ...
Drug Store News-4 hours ago
FLINT, Mich. — Diplomat Pharmacy raised almost $200 million Tuesday following the closing of its follow-on public ...
New York pharmacy owner Purna Chandra Aramalla sentenced to 3 ...
New York pharmacy owner Purna Chandra Aramalla sentenced to 3 ...
The American Bazaar-Mar 30, 2015
NEW YORK: A New York-based Indian American pharmacist and business owner Purna Chandra Aramalla, 67, of Port ...
The U.S. Securities and Exchange Commission on Wednesday brought its first enforcement action against a company for attempting to stifle the whistleblowing process through improperly restrictive language in a confidentiality agreement.
- April 1, 2015
BREAKING: SEC Brings 1st Case Over Employee Confidentiality Agreements
The U.S. Securities and Exchange Commission on Wednesday brought its first enforcement action against a company for attempting to stifle the whistleblowing process through improperly restrictive language in a confidentiality agreement.
FiercePharma Marketing Must Read Stories:
1. Vivus to slash obesity salesforce by one-third, turn to digital instead
2. Teva used kickbacks to boost Copaxone, Azilect scripts, feds say
3. Tiny Egalet scouting for 60 reps to hawk its new pain meds
4. Goal of J&J's pro soccer marketing deal? Scoring with millennials, Hispanics
5. Forget fighting over Flonase ads. GSK and J&J settle on fight for market share
2. Teva used kickbacks to boost Copaxone, Azilect scripts, feds say
3. Tiny Egalet scouting for 60 reps to hawk its new pain meds
4. Goal of J&J's pro soccer marketing deal? Scoring with millennials, Hispanics
5. Forget fighting over Flonase ads. GSK and J&J settle on fight for market share
Subscribe to:
Posts (Atom)